glp-1/gcgr dual agonist GLP-1-based therapies for type 2 diabetes: from single, and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Frontiers | GLP−1 receptor agonists

Capaldo B, Napoli R, Di Bonito P, Albano G, Sacc L

Dosing depends on the patient, their goals, the administration route, medical history, the product, and state laws

10.1371/journal.pone.0009367 PLoS One 174 KuidaK.ZhengT

Dietary L-carnitine supplementation also increased the expression of mTOR in the liver, suggesting that it has positive roles in protein synthesis

"Im concerned about the impact some may have on the kidneys

GLP-treatment could start to become highly personalized: As Horn put it to me, somebody with obstructive sleep apnea may still want to take Zepbound because that drug has proven effective for both that condition and weight loss at the same time